IIM
DAWN

INTECH Investment Management’s Day One Biopharmaceuticals DAWN Stock Holding History

INTECH Investment Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$443K Sell
20,680
-15,378
-43% -$217K ﹤0.01% 1393
2025
Q4 		$336K Buy
36,058
+4,790
+15% +$40K ﹤0.01% 1708
2025
Q3 		$220K Sell
31,268
-14,129
-31% -$97.2K ﹤0.01% 2010
2025
Q2 		$295K Sell
45,397
-5,767
-11% -$39.7K ﹤0.01% 1867
2025
Q1 		$406K Buy
51,164
+16,276
+47% +$175K ﹤0.01% 1726
2024
Q4 		$442K Buy
34,888
+11,652
+50% +$162K ﹤0.01% 1631
2024
Q3 		$324K Buy
+23,236
New +$332K ﹤0.01% 1469

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

INTECH Investment Management's DAWN Position: Q1 2026 in Review

INTECH Investment Management reduced its Day One Biopharmaceuticals (DAWN) stake by 43% in Q1 2026, selling an estimated $217K and leaving 20,680 shares worth $443K. The position accounts for ﹤0.01% of the portfolio, ranked #1393.

INTECH Investment Management first reported a position in DAWN in Q3 2024 and has held it in 7 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • INTECH Investment Management held 20,680 shares of Day One Biopharmaceuticals worth $443K as of Q1 2026.
  • INTECH Investment Management sold 15,378 Day One Biopharmaceuticals shares in Q1 2026, an estimated $217K.
  • Day One Biopharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1393 holding.
  • INTECH Investment Management first reported a position in Day One Biopharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.